Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.53B | 15.62B | 16.66B | 16.11B | 15.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.53B | 15.62B | 16.66B | 16.11B | 15.78B |
| Cost of Revenue | 3.38B | 3.71B | 3.89B | 3.68B | 3.42B |
| Gross Profit | 12.15B | 11.92B | 12.77B | 12.43B | 12.35B |
| SG&A Expenses | 2.40B | 2.69B | 2.54B | 2.55B | 2.32B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.31B | 10.28B | 12.29B | 9.10B | 9.08B |
| Operating Income | 6.22B | 5.34B | 4.36B | 7.02B | 6.70B |
| Income Before Tax | 5.90B | 4.17B | 4.09B | 6.01B | 5.67B |
| Income Tax Expenses | 818.00M | 426.00M | 929.00M | 545.00M | 903.00M |
| Earnings from Continuing Operations | 5.09B | 3.74B | 3.16B | 5.46B | 4.77B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.00M | -1.00M | -4.00M | -6.00M | -5.00M |
| Net Income | 5.08B | 3.74B | 3.16B | 5.46B | 4.76B |
| EBIT | 6.22B | 5.34B | 4.36B | 7.02B | 6.70B |
| EBITDA | 7.28B | 6.46B | 5.51B | 8.08B | 7.62B |
| EPS Basic | 2.01 | 1.48 | 1.25 | 2.15 | 1.88 |
| Normalized Basic EPS | 1.49 | 1.24 | 1.08 | 1.67 | 1.58 |
| EPS Diluted | 2.01 | 1.48 | 1.24 | 2.14 | 1.87 |
| Normalized Diluted EPS | 1.48 | 1.24 | 1.08 | 1.66 | 1.58 |
| Average Basic Shares Outstanding | 2.52B | 2.54B | 2.53B | 2.53B | 2.53B |
| Average Diluted Shares Outstanding | 2.53B | 2.54B | 2.54B | 2.54B | 2.54B |
| Dividend Per Share | 0.81 | 0.77 | 0.77 | 0.77 | 0.77 |
| Payout Ratio | 40.36% | 52.12% | 61.86% | 36.41% | 40.95% |